- Home
- POLA vs ALZN Comparison
POLA vs ALZN Comparison
Compare POLA & ALZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POLA
- ALZN
- Stock Information
- Founded
- POLA 1979
- ALZN 2016
- Country
- POLA United States
- ALZN United States
- Employees
- POLA N/A
- ALZN N/A
- Industry
- POLA Industrial Machinery/Components
- ALZN Medicinal Chemicals and Botanical Products
- Sector
- POLA Miscellaneous
- ALZN Health Care
- Exchange
- POLA Nasdaq
- ALZN Nasdaq
- Market Cap
- POLA 5.6M
- ALZN 6.1M
- IPO Year
- POLA 2016
- ALZN 2021
- Fundamental
- Price
- POLA $2.10
- ALZN $0.70
- Analyst Decision
- POLA
- ALZN Strong Buy
- Analyst Count
- POLA 0
- ALZN 1
- Target Price
- POLA N/A
- ALZN $20.00
- AVG Volume (30 Days)
- POLA 15.9K
- ALZN 124.9K
- Earning Date
- POLA 05-14-2025
- ALZN 03-10-2025
- Dividend Yield
- POLA N/A
- ALZN N/A
- EPS Growth
- POLA N/A
- ALZN N/A
- EPS
- POLA N/A
- ALZN N/A
- Revenue
- POLA $13,970,000.00
- ALZN N/A
- Revenue This Year
- POLA N/A
- ALZN $322.64
- Revenue Next Year
- POLA N/A
- ALZN N/A
- P/E Ratio
- POLA N/A
- ALZN N/A
- Revenue Growth
- POLA N/A
- ALZN N/A
- 52 Week Low
- POLA $1.78
- ALZN $0.64
- 52 Week High
- POLA $4.90
- ALZN $15.06
- Technical
- Relative Strength Index (RSI)
- POLA 40.75
- ALZN 35.54
- Support Level
- POLA $2.02
- ALZN $0.67
- Resistance Level
- POLA $2.27
- ALZN $0.71
- Average True Range (ATR)
- POLA 0.15
- ALZN 0.07
- MACD
- POLA 0.02
- ALZN -0.02
- Stochastic Oscillator
- POLA 54.33
- ALZN 10.43
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.
About ALZN Alzamend Neuro Inc.
Alzamend Neuro Inc is an early clinical-stage biopharmaceutical company. It is focused on developing novel products for the treatment of neurodegenerative diseases and psychiatric disorders, including Alzheimer's. Its mission is to develop and market safe and effective treatments. The company's pipeline consists of two novel therapeutic drug candidates, AL001 - a patented ionic cocrystal technology delivering lithium via a therapeutic combination of lithium, proline and salicylate, and AL002 - a patented method using a mutant-peptide sensitized cell as a cell-based therapeutic vaccine that seeks to restore the ability of a patient's immunological system to combat Alzheimer's.